CDMO Recipharm has appointed Joaquim Mascaro as Chief Financial Officer.
Mascaro has worked for a range of organisations in the pharma, biotech and healthcare industries, across the US, Asia and Latin America. He joins Recipharm from Sonova Group, where he was Division CFO for hearing instruments, and previously held roles with GSK and Novartis.
Joaquim joined Recipharm on April 3 and replaces Michael Tyroller, who was interim CFO.
Providence Therapeutics partners with University Health Network for mRNA development
invoX Pharma increases investment in pHion Therapeutics to develop mRNA vaccines
Merck study: mRNA technology a ‘game changer’ for Asia-Pacific vaccine manufacturers
Moderna forges ahead with mRNA therapy after positive early clinical data
